Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Cloning Prohibited. More details...
Developments In East-West Pharma Simcere Pharma, which...
Biotech Off Slightly. More details...
Company Reports Lower Q1 Results On May 21, Benda...
Benda Now Holds 60% of SiBiono Benda Pharma (Bulletin...
IP for Cancer Gene Therapy at Issue -- A Washington Post...
Side-Effects Prompt Response -- On Saturday, the Chinese...
Benda Pharmaceutical announced the appointment of a third...
Benda reported that a national forum on “Gene...
Consolidation in China biotech was a major theme last...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
